Category: Clinical Breakthroughs
-
Northwestern Team Develops New Antibody Test for COVID-19
Northwestern University scientists have developed a new method for testing for SARS-CoV-2 (the virus that causes COVID-19) antibodies, requiring only a single drop of blood collected from a simple finger prick.
-
First Wearable Device Continuously Tracks COVID-19 Symptoms
Investigators at Northwestern University and Shirley Ryan AbilityLab in Chicago have developed a novel wearable device and are creating a set of data algorithms specifically tailored to catch early signs and symptoms associated with COVID-19.
-
First Trial Shows Benefit for Genomically Targeted Prostate Cancer Treatment
For the first time, advanced prostate cancer has been treated based on the genomic makeup of the cancer, delaying disease progression for patients with a treatment-resistant form of prostate cancer.
-
‘Caution Fatigue’ Could Dent Efforts to Stay Safe
Northwestern Medicine experts discuss the phenomenon of “caution fatigue,” where people may find it difficult to stay on high-risk alert after weeks of social distancing and isolation to stop the spread of COVID-19.
-
Novel Drug Shows Promise for Inherited Blood Disorder
A novel drug called luspatercept may reduce blood transfusion burden for patients with transfusion-dependent beta-thalassemia, an inherited blood disorder.
-
Novel Brain Mapping Technology Outperforms Current Platforms
A newly developed high-resolution brain mapping technology exceeds the lifespans of current platforms and may enhance how brain function is measured and how efficiently neurological diseases are diagnosed and treated.
-
Older Adults Didn’t Think COVID-19 Would Affect Them
Many individuals in the highest risk category for COVID-19 because of multiple chronic health conditions didn’t think the disease would affect them and reported not changing their behavior at the beginning of Chicago’s outbreak, according to a new study.
-
Heart Disease, Racial Disparities and COVID-19
Northwestern Medicine cardiovascular experts discuss how racial disparities, including lower socioeconomic status and pre-existing cardiovascular conditions, can lead African-Americans to be at higher risk for contracting and dying from COVID-19.
-
Sex May Influence Effectiveness of Common Heart Failure Drug
A novel heart failure drug called sacubitril-valsartan reduced the risk of hospitalizations for heart failure and death from cardiovascular causes more in women than in men, according to a study published in Circulation.
-
COVID-19 Drug Trial Launches at Northwestern Medicine
Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19, testing remdesivir, a novel anti-viral drug developed to treat Ebola, and which has also shown antiviral activity in coronaviruses.
